Digoxin pharmacokinetics: role of renal failure in dosage regimen design.
about
Digoxin population pharmacokinetics from routine clinical data: role of patient characteristics for estimating dosing regimens.Estimation of pharmacokinetic parameters based on the patient-adjusted population data.Glomerular filtration rate estimation using the Cockcroft-Gault and modification of diet in renal disease formulas for digoxin dose adjustment in patients with heart failure.Use of a simplified nomogram to individualize digoxin dosing versus standard dosing practices in patients with heart failure.Digoxin therapy: textbooks, theory and practice.Altered distribution of digoxin in renal failure--a cause of digoxin toxicity?Monitoring digoxin therapy: II. Determinants of the apparent volume of distribution.Monitoring digoxin therapy: III. How useful are the nomograms?Loading dose of digoxin in renal failure.Pharmacokinetics of gentamicin in 957 patients with varying renal function dosed once daily.Population pharmacokinetics and optimization of the dosing regimen of digoxin in adult patientsComputer-assisted review of digoxin therapy in the elderly.Digoxin-specific antibody fragments in the treatment of digoxin toxicity.Pharmacokinetic evaluation of hemodialysis in acute drug overdose.Hemoperfusion of digoxin intoxication.Distribution and elimination of digoxin in infants.Initial experience of clinical pharmacology and clinical pharmacy interactions in a clinical pharmacokinetics consultation service.Calculation of serum digoxin levels in patients with normal and impaired renal function.Population-based investigation of relative clearance of digoxin in Japanese patients by multiple trough screen analysis: an update.Evaluation of two prediction models for digoxin dosing.A simple aid to digoxin prescribing.Use of colestipol in a patient with digoxin intoxication.A pharmacokinetic model-independent approach for estimating dose required to give desired steady-state trough concentrations of drug in plasma.Predictive performance of four pharmacokinetic methods for calculating digoxin dosage.Concurrent renal dysfunction with ischemic heart disease is an important determinant for cardiac and cerebrovascular mortality in patients on chronic digoxin therapy for atrial fibrillation.
P2860
Q30841916-C8DD78FE-F2F4-4BB5-8BE7-65E86ED6100DQ31082856-FD71E486-5AED-4170-A298-AA2353999C61Q33781854-51DC3224-F495-4F5C-BD03-07A0202C8816Q34490600-ED001297-03DF-43D8-A19E-EF4257D5A881Q34515259-8066193D-50FE-4B8F-81E3-FF1C7977028BQ34515437-9546C96C-311A-4B93-897E-A8342766D057Q34515665-732EF0D0-4D20-4A41-8415-379F61379C9AQ34516197-D2BBA10C-43DC-4539-A015-7485F439255CQ34518837-E2151730-8581-4757-A4D4-19F07121C51FQ36053463-9A1ACCB7-0803-4D6D-A26B-E622D9FF1E2BQ36508024-B69B5ABF-93F0-4A90-A67A-F55E0283961DQ36762119-E52150D7-0892-460C-977D-E38E20694A6AQ38236647-6AC4E214-D112-446E-B9F0-8BF0E2893474Q39783091-739341E4-4BD6-412D-9DE5-13F4D43205E5Q40298702-03A81C11-9EE2-4A18-A768-ABAF49898329Q43550112-B272BC9F-6DE4-4F6F-B908-DF41D2A82F0DQ44480013-8DE46822-51C2-426C-A11B-EB338FD7CB7EQ50535699-E730E2EE-9E4E-4D09-B8CA-E1D5DD1BEBA3Q50970492-3C3463E2-6AB4-49B3-BA60-7D0068FD9A5EQ52400724-B64F06E7-0D3F-4D24-B739-3A59C8CE430CQ52614635-BE300D08-0F10-47DF-97E1-02933A84AD6BQ52733094-C1EB9A9A-D7B2-4F34-8E74-DA8F9AB83B60Q52765659-14E4C3DF-D8FE-4401-8336-3414C424281FQ52887073-9CFD0058-1247-4C78-B0C8-844D6154B177Q55498884-C64D72D9-7C0F-4288-A6FA-DF164D0B181A
P2860
Digoxin pharmacokinetics: role of renal failure in dosage regimen design.
description
1975 nî lūn-bûn
@nan
1975年の論文
@ja
1975年論文
@yue
1975年論文
@zh-hant
1975年論文
@zh-hk
1975年論文
@zh-mo
1975年論文
@zh-tw
1975年论文
@wuu
1975年论文
@zh
1975年论文
@zh-cn
name
Digoxin pharmacokinetics: role of renal failure in dosage regimen design.
@en
Digoxin pharmacokinetics: role of renal failure in dosage regimen design.
@nl
type
label
Digoxin pharmacokinetics: role of renal failure in dosage regimen design.
@en
Digoxin pharmacokinetics: role of renal failure in dosage regimen design.
@nl
prefLabel
Digoxin pharmacokinetics: role of renal failure in dosage regimen design.
@en
Digoxin pharmacokinetics: role of renal failure in dosage regimen design.
@nl
P2093
P356
P1476
Digoxin pharmacokinetics: role of renal failure in dosage regimen design.
@en
P2093
P356
10.1002/CPT19751819
P407
P577
1975-07-01T00:00:00Z